Literature DB >> 10452425

Prognostic factors in acute cardiogenic pulmonary edema.

P Le Conte1, V Coutant, J M N'Guyen, D Baron, M D Touze, G Potel.   

Abstract

The purpose of this study was to determine the clinical and biological findings at admission in the Department of Emergency Medicine associated with a poor prognosis, and to evaluate early response to treatment as a prognostic factor. It was a prospective cohort study with a 5-month follow-up. One hundred eighty-six patients admitted for acute cardiogenic pulmonary edema were included. Features were analyzed at the admission and on response to initial treatment. The main outcome measure was survival at 2 end-points: hospital discharge, and 5 months of follow-up. Multivariate analysis showed that in-hospital mortality was associated with marbleization (mottling) odd-ratio (OR) = 9.0), low diuresis (OR = 4.0), high breath rate 6 hours after admission (OR = 4.0), and chronic digoxin use (OR = 3.39). Five-month mortality was associated with a bedridden state (OR = 9.0), marbleization (mottling) (OR = 5.5), myocardial infarction (OR = 3), and poor early response to initial treatment (OR = 3.2). In addition to well-known factors, the response to initial treatment evaluated 6 hours after admission was a major determinant of outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10452425     DOI: 10.1016/s0735-6757(99)90078-5

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

1.  Is the noninvasive ventilatory mode of importance during cardiogenic pulmonary edema?

Authors:  Erwan L'Her
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

Review 2.  Non-invasive ventilation.

Authors:  Josep Masip
Journal:  Heart Fail Rev       Date:  2007-06       Impact factor: 4.214

3.  Risk factors for intubation as a guide for noninvasive ventilation in patients with severe acute cardiogenic pulmonary edema.

Authors:  Josep Masip; Joaquim Páez; Montserrat Merino; Sandra Parejo; Francisco Vecilla; Clara Riera; Araceli Ríos; Joan Sabater; Josep Ballús; J Padró
Journal:  Intensive Care Med       Date:  2003-09-10       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.